135 related articles for article (PubMed ID: 15712318)
1. Relevance of atypical protein kinase C isotypes to the drug discovery process.
Jenny M; Wrulich OA; Schwaiger W; Ueberall F
Chembiochem; 2005 Mar; 6(3):491-9. PubMed ID: 15712318
[No Abstract] [Full Text] [Related]
2. Preclinical and clinical development of novel agents that target the protein kinase C family.
Serova M; Ghoul A; Benhadji KA; Cvitkovic E; Faivre S; Calvo F; Lokiec F; Raymond E
Semin Oncol; 2006 Aug; 33(4):466-78. PubMed ID: 16890801
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a potent and selective inhibitor of protein kinase C isotypes.
Wagner J; von Matt P; Sedrani R; Albert R; Cooke N; Ehrhardt C; Geiser M; Rummel G; Stark W; Strauss A; Cowan-Jacob SW; Beerli C; Weckbecker G; Evenou JP; Zenke G; Cottens S
J Med Chem; 2009 Oct; 52(20):6193-6. PubMed ID: 19827831
[TBL] [Abstract][Full Text] [Related]
4. Genetic manipulation of protein kinase C in vivo.
Toker A
Methods Mol Biol; 2003; 233():475-89. PubMed ID: 12840530
[No Abstract] [Full Text] [Related]
5. Competitive inhibitors and allosteric activators of protein kinase C isoenzymes: a personal account and progress report on transferring academic discoveries to the clinic.
Budas GR; Koyanagi T; Churchill EN; Mochly-Rosen D
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1021-6. PubMed ID: 17956268
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C - a family of protein kinases, allosteric effectors or both?
Cameron AJ; Parker PJ
Adv Enzyme Regul; 2010; 50(1):169-77. PubMed ID: 19914278
[No Abstract] [Full Text] [Related]
7. Antisense oligonucleotide inhibitors of isozymes of protein kinase C: in vitro and in vivo activity, and clinical development as anti-cancer therapeutics.
McGraw K; McKay R; Miraglia L; Boggs RT; Pribble JP; Muller M; Geiger T; Fabbro D; Dean NM
Anticancer Drug Des; 1997 Jul; 12(5):315-26. PubMed ID: 9236849
[No Abstract] [Full Text] [Related]
8. [Role of PKCbeta in the malignant tumors and enzastaurin, a PKCbeta inhibitor].
Li XY; Chen XG
Yao Xue Xue Bao; 2009 May; 44(5):449-55. PubMed ID: 19618717
[TBL] [Abstract][Full Text] [Related]
9. C-5 Substituted heteroaryl 3-pyridinecarbonitriles as PKCtheta inhibitors: Part I.
Subrath J; Wang D; Wu B; Niu C; Boschelli DH; Lee J; Yang X; Brennan A; Chaudhary D
Bioorg Med Chem Lett; 2009 Sep; 19(18):5423-5. PubMed ID: 19682896
[TBL] [Abstract][Full Text] [Related]
10. Characterization of protein kinase C theta activation loop autophosphorylation and the kinase domain catalytic mechanism.
Czerwinski R; Aulabaugh A; Greco RM; Olland S; Malakian K; Wolfrom S; Lin L; Kriz R; Stahl M; Huang Y; Liu L; Chaudhary D
Biochemistry; 2005 Jul; 44(28):9563-73. PubMed ID: 16008341
[TBL] [Abstract][Full Text] [Related]
11. PKD at the crossroads of DAG and PKC signaling.
Wang QJ
Trends Pharmacol Sci; 2006 Jun; 27(6):317-23. PubMed ID: 16678913
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and PKCtheta inhibitory activity of a series of 4-indolylamino-5-phenyl-3-pyridinecarbonitriles.
Dushin RG; Nittoli T; Ingalls C; Boschelli DH; Cole DC; Wissner A; Lee J; Yang X; Morgan P; Brennan A; Chaudhary D
Bioorg Med Chem Lett; 2009 May; 19(9):2461-3. PubMed ID: 19345579
[TBL] [Abstract][Full Text] [Related]
13. Structure-based optimization of PKCtheta inhibitors.
Mosyak L; Xu Z; Joseph-McCarthy D; Brooijmans N; Somers W; Chaudhary D
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1027-31. PubMed ID: 17956269
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of protein kinase C.
Yamamoto T; Yamauchi E; Taniguchi H; Matsuzaki H; Kikkawa U
Methods Mol Biol; 2003; 233():207-16. PubMed ID: 12840509
[No Abstract] [Full Text] [Related]
15. Protein kinase C phosphorylation: an introduction.
Parker PJ
Methods Mol Biol; 2003; 233():159-62. PubMed ID: 12840505
[No Abstract] [Full Text] [Related]
16. Regulation of caspase 9 through phosphorylation by protein kinase C zeta in response to hyperosmotic stress.
Brady SC; Allan LA; Clarke PR
Mol Cell Biol; 2005 Dec; 25(23):10543-55. PubMed ID: 16287866
[TBL] [Abstract][Full Text] [Related]
17. Selective binding of phorbol esters and diacylglycerol by individual C1 domains of the PKD family.
Chen J; Deng F; Li J; Wang QJ
Biochem J; 2008 Apr; 411(2):333-42. PubMed ID: 18076381
[TBL] [Abstract][Full Text] [Related]
18. Targeting protein kinase C subtypes in pancreatic cancer.
Storz P
Expert Rev Anticancer Ther; 2015 Apr; 15(4):433-8. PubMed ID: 25604078
[TBL] [Abstract][Full Text] [Related]
19. Yeast as a host to screen for modulators and regulatory regions of mammalian protein kinase C isoforms.
Parissenti AM; Riedel H
Methods Mol Biol; 2003; 233():491-516. PubMed ID: 12840531
[No Abstract] [Full Text] [Related]
20. Protein kinase C intervention: the state of play.
Roffey J; Rosse C; Linch M; Hibbert A; McDonald NQ; Parker PJ
Curr Opin Cell Biol; 2009 Apr; 21(2):268-79. PubMed ID: 19233632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
